Nelson BE, Saleem S, Damodaran S, Somaiah N, et al. Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer. Cancer 2023 Apr 4. doi: 10.1002/cncr.34773.
PMID: 37016732